Crinetics Pharmaceuticals (CRNX) Non Operating Investment Income (2023)
Crinetics Pharmaceuticals has reported Non Operating Investment Income over the past 1 years, most recently at -$997000.0 for Q3 2023.
Crinetics Pharmaceuticals has reported Non Operating Investment Income over the past 1 years, most recently at -$997000.0 for Q3 2023.
| Date | Value |
|---|---|
Offer Ends In
Starting from $49 $19 / month